AbCellera Biologics Inc. (ABCL) Ownership

$3.31

north_east
$0.18 (5.75%)
Day's range
$3.15
Day's range
$3.43

AbCellera Biologics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 02/14/2025 27.53 M $80.65 M   0.00% 9.34%
BAILLIE GIFFORD & CO 01/31/2025 12.24 M $35.85 M   -5.10% 4.15%
VOYA INVESTMENT MANAGEMENT LLC 02/14/2025 10.62 M $31.13 M   0.00% 3.60%
CAPITAL WORLD INVESTORS 02/13/2025 7.93 M $23.25 M   100.00% 2.69%
PROSIGHT MANAGEMENT, LP 02/14/2025 7.35 M $21.54 M   -19.05% 2.49%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 4.50 M $13.19 M   -1.96% 1.53%
ORBIMED ADVISORS LLC 02/14/2025 4.18 M $12.25 M   0.00% 1.42%
ARROWMARK COLORADO HOLDINGS LLC 02/14/2025 4.11 M $12.03 M   0.00% 1.39%
BLACKROCK FUNDING, INC. /DE 02/07/2025 4.10 M $12.00 M   2.71% 1.39%
TWO SIGMA INVESTMENTS, LP 02/14/2025 3.26 M $9.54 M   28.56% 1.10%
TWO SIGMA ADVISERS, LP 02/14/2025 2.61 M $7.64 M   19.78% 0.88%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 2.58 M $7.57 M   12.30% 0.88%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 2.49 M $7.29 M   -15.60% 0.84%
UBS GROUP AG 02/14/2025 1.98 M $5.79 M   8,984.15% 0.67%
GUARDIAN PARTNERS INC. 02/11/2025 1.79 M $5.41 M   100.00% 0.61%
MILLENNIUM MANAGEMENT LLC 02/14/2025 1.48 M $4.34 M   96.68% 0.50%
NORGES BANK 02/12/2025 1.28 M $3.76 M   100.00% 0.44%
NOVO HOLDINGS A/S 02/14/2025 1.13 M $3.30 M   0.00% 0.38%
OPALEYE MANAGEMENT INC. 02/14/2025 965,000 $2.83 M   20.63% 0.33%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 928,594 $2.72 M   -15.32% 0.31%
FEDERATED HERMES, INC. 02/13/2025 916,237 $2.68 M   -59.86% 0.31%
GSA CAPITAL PARTNERS LLP 02/07/2025 589,213 $1.73 M   143.61% 0.20%
INTELLECTUS PARTNERS, LLC 02/07/2025 547,533 $1.60 M   0.37% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 417,396 $1.22 M   78.33% 0.14%
ROYAL BANK OF CANADA 02/14/2025 406,991 $1.19 M   -0.10% 0.14%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 02/10/2025 340,267 $959,553   0.00% 0.12%
STATE STREET CORP 02/14/2025 324,802 $951,670   0.49% 0.11%
DNB ASSET MANAGEMENT AS 02/12/2025 305,579 $895,346   424.72% 0.10%
GOLDMAN SACHS GROUP INC 02/11/2025 299,813 $878,452   45.75% 0.10%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 281,795 $826,000   100.00% 0.10%
JPMORGAN CHASE & CO 02/12/2025 281,033 $823,426   -21.00% 0.10%
HRT FINANCIAL LP 02/14/2025 250,226 $733,000   92.62% 0.08%
PIER 88 INVESTMENT PARTNERS LLC 02/12/2025 236,900 $694,117   21.18% 0.08%
PEAK6 LLC 02/13/2025 199,995 $585,985   100.00% 0.07%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 178,839 $521,000   1,237.51% 0.06%
ENTRYPOINT CAPITAL, LLC 02/11/2025 168,682 $494,238   43.98% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 166,300 $487,259   74.14% 0.06%
JANE STREET GROUP, LLC 02/14/2025 128,407 $376,232   21.19% 0.04%
TRUEMARK INVESTMENTS, LLC 02/12/2025 124,089 $363,581   -7.68% 0.04%
POLAR ASSET MANAGEMENT PARTNERS INC. 02/25/2025 117,830 $345,242   0.00% 0.04%
AMERICAN CENTURY COMPANIES INC 02/11/2025 116,887 $342,479   -0.20% 0.04%
ARCHPOINT INVESTORS 02/13/2025 115,055 $337,111   0.00% 0.04%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 113,773 $333,354   0.11% 0.04%
TD WATERHOUSE CANADA INC. 02/13/2025 104,594 $306,460   -55.00% 0.04%
ADVISOR GROUP HOLDINGS, INC. 02/07/2025 104,365 $271,600   0.11% 0.04%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/14/2025 103,610 $303,577   100.00% 0.04%
XTX TOPCO LTD 02/13/2025 91,754 $268,839   100.00% 0.03%
MOLONEY SECURITIES ASSET MANAGEMENT, LLC 01/28/2025 90,400 $264,872   100.00% 0.03%
01/31/2025 89,616 $289,460   -5.78% 0.03%
GROUP ONE TRADING, L.P. 02/14/2025 89,204 $261,368   18.96% 0.03%

AbCellera Biologics Inc. institutional Ownership - FAQ's

During the previous two years, 178 institutional investors and hedge funds held shares of AbCellera Biologics Inc.. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 27.53 M

BAILLIE GIFFORD & CO: 12.24 M

VOYA INVESTMENT MANAGEMENT LLC: 10.62 M

Capital World Investors: 7.93 M

Prosight Management, LP: 7.35 M

UBS ASSET MANAGEMENT AMERICAS INC: 4.5 M

38.62% of AbCellera Biologics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 133.64 M shares in the last 24 months. This purchase volume represents approximately $442.34 M in transactions.